Drug class

Cyclic Lipopeptides

Cyclic lipopeptides are a distinct class of antibacterial agents characterized by a cyclic peptide core attached to a lipophilic fatty acid tail. Read more about Cyclic Lipopeptides

25 drugs in this class 25 manufacturers

Advertisement

Drugs in Cyclic Lipopeptides

Showing 1–9 of 25 drugs

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
FRESENIUS KABI

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
Hospira

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
XELLIA PHARMACE

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
MYLAN INSTITUTI

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
NORTHSTAR RX LL

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
DR.REDDY'S LAB

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
BLUEPOINT LABOR

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
CIVICA, INC.

DAPTOMYCIN

AGENTS TO TREAT RESISTANT GRAM POSITIVE ORGANISMS · STAPHYLOCOCCUS AUREUS SEPTICEMIA ·+6
BE PHARMACEUTIC
Filter & compare in the drug finder → Opens the drug finder with Cyclic Lipopeptides preselected. Add indication or manufacturer filters there.

About Cyclic Lipopeptides.

Cyclic lipopeptides are a distinct class of antibacterial agents characterized by a cyclic peptide core attached to a lipophilic fatty acid tail.

They exert rapid, concentration-dependent bactericidal activity primarily by inserting into bacterial cell membranes in a calcium-dependent manner, triggering rapid membrane depolarization, disruption of membrane integrity, and subsequent arrest of essential cellular synthesis pathways.

In clinical practice, this class—principally represented by daptomycin—is reserved for serious infections caused by multidrug-resistant Gram-positive pathogens.

Major therapeutic applications include complicated skin and skin structure infections, *Staphylococcus aureus* bacteremia, and right-sided infective endocarditis.